¼¼°èÀÇ ¸¾¸ð±×·¡ÇÇ ½Ã½ºÅÛ ½ÃÀå(2021-2027³â) : ½ÃÀå ¿¹Ãø(Á¦Ç°, ±â¼ú, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº°), »ê¾÷ µ¿Çâ, Áö¿ªÀû Àü¸Á, ½ÃÀå Á¡À¯À²
Mammography Systems Market Size By Product (Analog Systems, Full Field Digital Mammography System, Breast Tomosynthesis System), By Technology, By End-use, Industry Analysis Report, Regional Outlook, Competitive Market Share & Forecast, 2021 - 2027
¼¼°èÀÇ ¸¾¸ð±×·¡ÇÇ ½Ã½ºÅÛ ½ÃÀåÀº À¯¹æ¾ÏÀÇ ¹ßÁõ·ü Áõ°¡ µîÀÇ ¿äÀο¡ ÀÇÇØ ÇâÈÄ ¼ö³â°£ ´ëÆøÀûÀÎ ¼ºÀåÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¦Ç°º°·Î º¸¸é ¾Æ³¯·Î±× ½Ã½ºÅÛ ºÎ¹®ÀÌ 2020³â¿¡ 1¾ï 3000¸¸ ´Þ·¯ ÀÌ»óÀÇ ±Ô¸ð¸¦ º¸À̸ç, ÇâÈÄ ¼ö³â°£ ³ôÀº ¼ö¿ä¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù. ÀÌ Á¦Ç° À¯ÇüÀº Àúºñ¿ëÀ̹ǷΠ½ÅÈï ±¹°¡¿¡¼ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ¸¾¸ð±×·¡ÇÇ ½Ã½ºÅÛ ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ Á¤ÀÇ¿Í °³¿ä, »ê¾÷ ¿¡ÄڽýºÅÛ, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ(COVID-19) ¹× ±âŸ ½ÃÀå ¿µÇâ¿äÀÎ ºÐ¼®, ¹ý±ÔÁ¦¡¤»óȯ ȯ°æ, ±â¼ú µ¿Çâ, ½ÃÀå ±Ô¸ðÀÇ ÃßÀÌ¡¤¿¹Ãø, Á¦Ç°¡¤±â¼ú¡¤ÃÖÁ¾»ç¿ëÀÚ¡¤Áö¿ª/ÁÖ¿ä ±¹°¡ µî °¢Á¾ ºÎ¹®º° ³»¿ª, °æÀï ȯ°æ, ÁÖ¿ä ±â¾÷ÀÇ °³¿ä µîÀ» Á¤¸®ÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
Á¦1Àå Á¶»ç ¹æ¹ý
Á¦2Àå °³¿ä
Á¦3Àå »ê¾÷ ÀλçÀÌÆ®
- »ê¾÷ ¼¼ºÐÈ
- »ê¾÷ »óȲ
- »ê¾÷¿¡ ´ëÇÑ ¿µÇâ¿äÀÎ
- ¼ºÀå¿äÀÎ
- ÀáÀçÀû ¸®½ºÅ© & °úÁ¦
- ¼ºÀå °¡´É¼º
- COVID-19 : ¿µÇ⠺м®
- ±ÔÁ¦ »óȲ
- »óȯ »óȲ
- ±â¼ú »óȲ
- °¡°Ý ºÐ¼®
- PorterÀÇ »ê¾÷ ºÐ¼®
- °æÀï ±¸µµ
- PESTEL ºÐ¼®
Á¦4Àå ½ÃÀå ºÐ¼®¡¤¿¹Ãø : Á¦Ç°º°
- ¾Æ³¯·Î±× ½Ã½ºÅÛ
- FFDM(Full field digital mammography)
- À¯¹æ Åä¸ð½ÅÅ׽ýº
Á¦5Àå ½ÃÀå ºÐ¼®¡¤¿¹Ãø : ±â¼úº°
- ½ºÅ©¸° Çʸ§
- 2D ¸¾¸ð±×·¡ÇÇ
- 3D ¸¾¸ð±×·¡ÇÇ
- ±âŸ
Á¦6Àå ½ÃÀå ºÐ¼®¡¤¿¹Ãø : ÃÖÁ¾»ç¿ëÀÚº°
Á¦7Àå ½ÃÀå ºÐ¼®¡¤¿¹Ãø : Áö¿ª¡¤ÁÖ¿ä ±¹°¡º°
- ºÏ¹Ì
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿¡¤¾ÆÇÁ¸®Ä«
Á¦8Àå ±â¾÷ °³¿ä
- °æÀï ´ë½Ãº¸µå
- Analogic Corporation
- Canon Medical Systems Corporation(Toshiba Medical Systems Corporation)
- Carestream Health, Inc
- Delphinus Medical Technologies
- Fujifilm Holdings Corporation
- GE Healthcare
- Hologic
- IMS Giotto S P A
- Konica Minolta, Inc
- Siemens Healthineers
- Koninklijke Philips N.V.
- NP JSC Amico
- Planmed Oy
KSA 21.02.19
Title:
Mammography Systems Market Size By Product (Analog Systems, Full Field Digital Mammography System (FFDM), Breast Tomosynthesis System), By Technology (Screen Film, 2D Mammography, 3D Mammography), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Competitive Market Share & Forecast, 2021 - 2027.
The global mammography systems market is gaining momentum and it is poised to experience substantial growth in the forthcoming years. This growth will be largely driven by the increasing occurrence of breast cancer globally. Mammography is a type of breast imaging technology which uses low dose x-rays for the detection of cancer.
It can detect changes in the breast tissues up to a couple of years before it is palpable. The technology continues to be the leading modality in the early detection and prevention of breast cancer, which remains one of the leading causes of death among women worldwide. In terms of the product, the mammography systems industry is bifurcated into analog systems, breast tomosynthesis systems, and full field digital mammography systems.
Analog systems had captured a market share of more than USD 130 million in 2020 and are slated to witness a notable demand over the next few years. These systems are still widely used in some underdeveloped and developing economies due to lower cost.
Analog mammography systems do not have a digital detector, which is an expensive and fragile part. As a result, repair and maintenance costs for these systems are considerably less. This also makes it easier for healthcare providers to find a company that will offer a service contract for analog systems. Moreover, analog images captured via these system can be easily transformed into digital systems using a CR, eliminating the need for investing in expensive digital systems.
The different types of mammography technologies include 2D mammography, 3D mammography, screen film, and others. It is estimated that the industry share from other technologies will witness a CAGR of over 6.1% between 2021-2027. The segment includes synthesized 2D mammography and combined 2D and 3D mammography technology which provide better diagnostic efficiency compared to other systems.
On the basis of end-user, the mammography systems market is segmented into ambulatory surgical centers, hospitals, and others. The other end-users segment had captured more than 13% of the industry share in terms of revenue in 2020 and is expected to grow in the future. The segment includes diagnostic centers and mobile vans. Ongoing investments in healthcare infrastructure in developing countries and the widespread adoption of mammography technologies across diagnostic centers will drive the segment growth.
From a geographical point of view, the mammography systems industry in North was estimated to be worth USD 730 million in 2020 and will witness robust growth up to 2027 led by the U.S. The regional trends will be largely driven by a well-established healthcare system and the presence of numerous major healthcare devices, equipment, and technology manufacturers.
The regional customers undergoing mammography can avail numerous insurance coverage and reimbursement policies. In addition, increasing investments by leading healthcare providers in modern technologies will certainly boost the regional adoption of digital mammography systems.
Table of Contents
Chapter 1 Methodology
- 1.1 Market definitions
- 1.2 Base estimates and working
- 1.2.1 North America
- 1.2.2 Europe
- 1.2.3 Asia Pacific
- 1.2.4 Latin America
- 1.2.5 MEA
- 1.3 Forecast calculations
- 1.4 Data validation
- 1.5 Data sources
- 1.5.1 Secondary
- 1.5.1.1 Paid sources
- 1.5.1.2 Unpaid sources
- 1.5.2 Primary
Chapter 2 Executive Summary
- 2.1 Mammography market industry 360 degree synopsis
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Technology trends
- 2.1.4 End-use trends
- 2.1.5 Regional trends
Chapter 3 Mammography Market Industry Insights
- 3.1 Industry segmentation
- 3.2 Industry landscape, 2016 - 2027 (USD Million)
- 3.3 Industry impact forces
- 3.3.1 Growth drivers
- 3.3.1.1 Increasing incidence of breast cancer across the globe
- 3.3.1.2 Rising awareness about breast cancer screening and early detection in developed countries
- 3.3.1.3 Rising government funding for breast cancer screening tests in developed countries
- 3.3.1.4 Technological advancement in developed countries
- 3.3.2 Industry pitfalls & challenges
- 3.3.2.1 High capital investment
- 3.3.2.2 False-negative result
- 3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By technology
- 3.4.3 By end-use
- 3.5 COVID-19 impact analysis
- 3.6 Regulatory landscape
- 3.7 Reimbursement landscape
- 3.8 Technology landscape
- 3.9 Pricing analysis
- 3.10 Porter's analysis
- 3.11 Competitive landscape, 2020
- 3.12 PESTEL analysis
Chapter 4 Mammography Market, By Product
- 4.1 Key segment trends
- 4.2 Analog System
- 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
- 4.3 Full field digital mammography
- 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
- 4.4 Breast tomosynthesis
- 4.4.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 5 Mammography Market, By Technology
- 5.1 Key segment trends
- 5.2 Screen film
- 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
- 5.3 2D mammography
- 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
- 5.4 3D mammography
- 5.4.1 Market size, by region, 2016 - 2027 (USD Million)
- 5.5 Others
- 5.5.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 6 Mammography Market, By End-use
- 6.1 Key segment trends
- 6.2 Hospitals
- 6.2.1 Market size, by region, 2016 - 2027 (USD Million)
- 6.3 Ambulatory surgical centers
- 6.3.1 Market size, by region, 2016 - 2027 (USD Million)
- 6.4 Others
- 6.4.1 Market size, by region, 2016 - 2027 (USD Million)
Chapter 7 Mammography Market, By Region
- 7.1 Key regional trends
- 7.2 North America
- 7.2.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.2.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.2.3 Market size, by technology, 2016-2027 (USD Million)
- 7.2.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.2.5 U.S.
- 7.2.5.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.2.5.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.2.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.2.6 Canada
- 7.2.6.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.2.6.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.2.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3 Europe
- 7.3.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.3.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.3.3 Market size, by technology, 2016-2027 (USD Million)
- 7.3.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.5 Germany
- 7.3.5.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.3.5.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.3.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.6 UK
- 7.3.6.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.3.6.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.3.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.7 France
- 7.3.7.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.3.7.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.3.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.8 Spain
- 7.3.8.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.3.8.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.3.8.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.3.9 Italy
- 7.3.9.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.3.9.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.3.9.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4 Asia Pacific
- 7.4.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.4.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.4.3 Market size, by technology, 2016-2027 (USD Million)
- 7.4.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4.5 Japan
- 7.4.5.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.4.5.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.4.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4.6 China
- 7.4.6.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.4.6.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.4.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.4.7 India
- 7.4.7.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.4.7.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.4.7.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.5 Latin America
- 7.5.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.5.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.5.3 Market size, by technology, 2016-2027 (USD Million)
- 7.5.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.5.5 Brazil
- 7.5.5.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.5.5.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.5.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.5.6 Mexico
- 7.5.6.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.5.6.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.5.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.6 Middle East & Africa
- 7.6.1 Market size, by country, 2016 - 2027 (USD Million)
- 7.6.2 Market size, by product, 2016 - 2027 (USD Million)
- 7.6.3 Market size, by technology, 2016-2027 (USD Million)
- 7.6.4 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.6.5 South Africa
- 7.6.5.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.6.5.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
- 7.6.6 Saudi Arabia
- 7.6.6.1 Market size, by Product, 2016 - 2027 (USD Million)
- 7.6.6.2 Market size, by technology, 2016 - 2027 (USD Million)
- 7.6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
Chapter 8 Company Profiles
- 8.1 Competitive dashboard, 2020
- 8.2 Analogic Corporation
- 8.2.1 Business overview
- 8.2.2 Financial data
- 8.2.3 Product landscape
- 8.2.4 Strategic outlook
- 8.2.5 SWOT analysis
- 8.3 Canon Medical Systems Corporation (Toshiba Medical Systems Corporation)
- 8.3.1 Business overview
- 8.3.2 Financial data
- 8.3.3 Product landscape
- 8.3.4 Strategic outlook
- 8.3.5 SWOT analysis
- 8.4 Carestream Health, Inc
- 8.4.1 Business overview
- 8.4.2 Financial data
- 8.4.3 Product landscape
- 8.4.4 Strategic outlook
- 8.4.5 SWOT analysis
- 8.5 Delphinus Medical Technologies
- 8.5.1 Business overview
- 8.5.2 Financial data
- 8.5.3 Product landscape
- 8.5.4 Strategic outlook
- 8.5.5 SWOT analysis
- 8.6. Fujifilm Holdings Corporation
- 8.6.1 Business overview
- 8.6.2 Financial data
- 8.6.3 Product landscape
- 8.6.4 Strategic outlook
- 8.6.5 SWOT analysis
- 8.7 GE Healthcare
- 8.7.1 Business overview
- 8.7.2 Financial data
- 8.7.3 Product landscape
- 8.7.4 Strategic outlook
- 8.7.5 SWOT analysis
- 8.8 Hologic
- 8.8.1 Business overview
- 8.8.2 Financial data
- 8.8.3 Product landscape
- 8.8.4 Strategic outlook
- 8.8.5 SWOT analysis
- 8.9 IMS Giotto S P A
- 8.9.1 Business overview
- 8.9.2 Financial data
- 8.9.3 Product landscape
- 8.9.4 Strategic outlook
- 8.9.5 SWOT analysis
- 8.10 Konica Minolta, Inc
- 8.10.1 Business overview
- 8.10.2 Financial data
- 8.10.3 Product landscape
- 8.10.4 Strategic outlook
- 8.10.5 SWOT analysis
- 8.11 Siemens Healthineers
- 8.11.1 Business overview
- 8.11.2 Financial data
- 8.11.3 Product landscape
- 8.11.4 Strategic outlook
- 8.11.5 SWOT analysis
- 8.12 Koninklijke Philips N.V.
- 8.12.1 Business overview
- 8.12.2 Financial data
- 8.12.3 Product landscape
- 8.12.4 Strategic outlook
- 8.12.5 SWOT analysis
- 8.13 NP JSC Amico
- 8.13.1 Business overview
- 8.13.2 Financial data
- 8.13.3 Product landscape
- 8.13.4 Strategic outlook
- 8.13.5 SWOT analysis
- 8.14 Planmed Oy
- 8.14.1 Business overview
- 8.14.2 Financial data
- 8.14.3 Product landscape
- 8.14.4 Strategic outlook
- 8.14.5 SWOT analysis